HYNIC-PSMA is used for molecular imaging of tumors, particularly in the study of prostate cancer, by targeting the prostate-specific membrane antigen (PSMA) expressed on prostate cancer cells and enabling radiolabeling with isotopes such as 188Re via the HYNIC moiety.